By Philip van Doorn, MarketWatch
MarketWatch photo illustration/iStockphoto, Constellation Brands
Randy Hare, the director of equity research at Huntington Private Bank in Cincinnati, said Constellation Brands is setting itself apart in the U.S. beer industry by spending money wisely, with long-term returns for shareholders in mind.
Constellation Brands /zigman2/quotes/207737284/composite STZ -0.14% produces beer, wine and liquor in several countries, and its Corona and Modelo beer brands are growing in the U.S., while competitors are suffering. Constellation, based in Victor, N.Y., agreed earlier this month to sell about 30 of its lower-priced wine and spirits brands to E. & J. Gallo Winery for $1.7 billion.
Tapping into a fast-growing industry, Constellation now holds a 36.6% stake in Smiths Falls, Ontario-based Canopy Growth Corp. /zigman2/quotes/202205609/delayed CA:WEED -5.59% /zigman2/quotes/200603886/composite CGC -5.96% , with warrants that enable it to increase its stake in the largest publicly traded U.S. or Canadian marijuana company to more than 50%.
Canopy itself has been negotiating a deal for the right to acquire Acreage Holdings when or if the recreational use of marijuana becomes federally legal in the U.S.
In an interview, Hare said selling part of the low-priced wine business “gives [Constellation] some flexibility to invest in their CBD market.” CBD stands for cannabidiol, a non-psychoactive ingredient in marijuana that’s known as a treatment for seizures, anxiety and pain. CBD-infused products are growing in popularity.
“This is stuff that can show up in a lotion or a drink or anything like that,” said Hare, whose team manages about $17.5 billion for private clients. “They are allowed to sell these products [in the U.S.] because they are not classified as drugs.”
Through its investment in Canopy, Constellation has booked paper gains of 60% just this year. The company also has been able to participate in a growing cannabis product market. Over the long term, there are great possibilities with Canopy as the regulatory environment for recreational marijuana use in the U.S. loosens.
Looking beyond the cannabis business, Hare said Constellation is “the only beer company that can show growth” in the U.S. “The Mexican import market has continued to grow and has been the one bright spot in the U.S. beer industry,” he said.
When asked about craft brewers’ increasing market share, he said: It has not been pressuring Constellation Brands. It is almost a different market. The craft-beer trend has been going on for years, while Constellation has grown their Corona and Modelo imports [from Mexico].”
Four publicly traded companies’ brands dominated the list of the top 25 beer brands in the U.S. in 2017, based on the most recent data compiled by the Beer Institute and National Beer Wholesalers Association .
• Constellation Brands’ fiscal 2018 ended Feb. 28. The company said its annual comparable net sales were up 7% while its gross profit was also up 7% and operating income increased 6%. Beer sales for the fiscal year were up 11.6%, while shipment volume was up 9.7% and operating income from beer sales was up 11%.
• Anheuser-Busch InBev SA /zigman2/quotes/209225053/composite BUD +0.39% reported a 3.2% decline in global sales for 2018, with a 2.3% decline in gross profit. The company estimated that total U.S. beer sales to retailers (“adjusted for the number of selling days”) were down 1.8% in 2018, while estimating that its own adjusted beer sales to U.S. retailers were down 2.7%, with shipment volumes down 2.6%.
• Molson Coors /zigman2/quotes/205165133/composite TAP +0.89% said net sales for 2018 were down 2.1% from a year earlier, while adjusted gross profit was down 6.4% and operating income was down 4.8%. The company’s U.S. delivery volume was down 3.9% for the year, while deliveries to wholesalers were down 4.4%.
• Heineken NV /zigman2/quotes/206351165/delayed HEINY +0.36% /zigman2/quotes/205347870/delayed NL:HEIA +0.56% said it’s U.S. beer sales volume declined during 2018. However, net revenue increased by 6.1% and its operating profit was up 6.4%.